ストックスクリーナーアプリを入手
1.68
1.75%
-0.03
前日終値:
$1.71
開ける：
$1.66
24時間の取引高:
1,994
Relative Volume:
0.19
時価総額：
$7.73M
収益：
$4.33M
当期純損益:
$-4.17M
株価収益率:
-1.1235
EPS:
-1.4953
ネットキャッシュフロー:
$-3.19M
1週間 パフォーマンス:
-10.40%
1か月 パフォーマンス:
-39.57%
6か月 パフォーマンス:
-22.94%
1年 パフォーマンス:
-42.66%
1日の値動き範囲:
$1.66
$1.71
1週間の範囲:
$1.60
$1.85
52週間の値動き範囲:
$1.45
$3.20
Biomerica Inc Stock (BMRA) Company Profile
Compare BMRA vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
1.68 | 7.73M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-05-05 | 開始されました | Citizens | Mkt Outperform |
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Biomerica Q1FY27 Results: Net loss $1.2M, revenue falls 8% YoY - scanx.trade
Biomerica, Inc. Posts $1.23 Million Fiscal First-Quarter Loss as Sales Fall 8% - TOKENPOST
Diagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders - TradingView
Biomerica Reports First Quarter Fiscal 2027 Financial Results - The Manila Times
Biomerica Reports First Quarter Fiscal 2027 Financial Results - The Manila Times
BRIEF-Biomerica Q1 Net Income USD -1.2 Million - TradingView
BIOMERICA INC 1Q FY2027: Revenue $1.27M, EPS $(0.37) — 10-Q Summary - TradingView
Compensation chair will not stand for re-election at Biomerica (BMRA)'s December 11 annual meeting. - Stock Titan
Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2026 - www.marketscreener.com
BIOMERICA INC SEC Filing (Oct 8, 2026) - Stock Titan
BIOMERICA INC SEC Filing (Oct 8, 2026) - Stock Titan
CEO and directors bought into Biomerica (BMRA)'s $2.23 million share sale. - Stock Titan
Form S-3 Biomerica Inc For: 26 September By Investing.com - Investing.com Nigeria
Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants - TradingView
Biomerica Files $250 Million Mixed Shelf - marketscreener.com
Biomerica Files $250 Million Mixed Shelf - Yahoo Finance
Form S-3 Biomerica Inc For: 24 September - Investing.com India
Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com Nigeria
Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com UK
Biomerica files prospectus for resale of 1.4 million shares - scanx.trade
Biomerica Stock Price Forecast. Should You Buy BMRA? - StockInvest.us
Biomerica Inc. (BMRA) Holds Near $2.36 as Traders Eye Tight RangeDiamond Pattern - siam.in
Biomerica (BMRA) gets new B. Riley-linked shareholder - stocktitan.net
Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan
Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal
Biomerica (BMRA) Gains 1.35% as Shares Test Key Level Near $2.36Cash Secured Put - dars.gov.et
BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Loo - GuruFocus
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Nigeria
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Australia
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com India
Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Canada
Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer
BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media
Biomerica reports fiscal 2026 revenue and product updates - grafa.com
Biomerica Reports Q4 Results - Orange County Business Journal
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative
BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView
Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com
Biomerica announces USD 2.23M financing - medicalbuyer.co.in
Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan
Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake - TradingView
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com Canada
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com South Africa
Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com India
Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
Biomerica Inc (BMRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MOATAZEDI DAVID | Director |
Aug 26 '26 |
Buy |
1.60 |
10,000 |
16,000 |
40,625 |
| Chin Eric | Director |
Aug 26 '26 |
Buy |
1.60 |
6,250 |
10,000 |
38,750 |
| BARBIERI ALLEN | Executive Vice Chairman |
Aug 26 '26 |
Buy |
1.60 |
20,000 |
32,000 |
73,542 |
| Irani Zackary S. | Chief Executive Officer |
Aug 26 '26 |
Buy |
1.60 |
31,250 |
50,000 |
242,570 |
7.54%
3.10%
大文字化:
|
ボリューム (24 時間):